Harpoon Therapeutics Inc (DELISTED) (HARP:DL)
23.01
0.00 (0.00%)
USD |
NASDAQ |
Mar 11, 16:00
Harpoon Therapeutics Max Drawdown (5Y): 98.67% for Feb. 29, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| February 29, 2024 | 98.67% |
| January 31, 2024 | 98.67% |
| December 31, 2023 | 98.67% |
| November 30, 2023 | 98.67% |
| October 31, 2023 | 98.67% |
| September 30, 2023 | 98.40% |
| August 31, 2023 | 97.79% |
| July 31, 2023 | 97.79% |
| June 30, 2023 | 97.79% |
| May 31, 2023 | 97.79% |
| April 30, 2023 | 97.73% |
| March 31, 2023 | 97.58% |
| February 28, 2023 | 97.58% |
| January 31, 2023 | 97.58% |
| December 31, 2022 | 97.58% |
| November 30, 2022 | 97.28% |
| October 31, 2022 | 96.54% |
| September 30, 2022 | 96.54% |
| August 31, 2022 | 93.28% |
| July 31, 2022 | 92.80% |
| June 30, 2022 | 92.80% |
| May 31, 2022 | 92.80% |
| April 30, 2022 | 90.90% |
| March 31, 2022 | 85.68% |
| February 28, 2022 | 83.41% |
| Date | Value |
|---|---|
| January 31, 2022 | 80.06% |
| December 31, 2021 | 76.98% |
| November 30, 2021 | 75.77% |
| October 31, 2021 | 75.24% |
| September 30, 2021 | 68.12% |
| August 31, 2021 | 65.61% |
| July 31, 2021 | 60.40% |
| June 30, 2021 | 55.46% |
| May 31, 2021 | 55.46% |
| April 30, 2021 | 55.46% |
| March 31, 2021 | 55.46% |
| February 28, 2021 | 55.46% |
| January 31, 2021 | 55.46% |
| December 31, 2020 | 55.46% |
| November 30, 2020 | 55.46% |
| October 31, 2020 | 55.46% |
| September 30, 2020 | 55.46% |
| August 31, 2020 | 55.46% |
| July 31, 2020 | 55.46% |
| June 30, 2020 | 47.81% |
| May 31, 2020 | 47.81% |
| April 30, 2020 | 47.81% |
| March 31, 2020 | 47.81% |
| February 29, 2020 | 44.33% |
| January 31, 2020 | 44.33% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
44.33%
Minimum
Nov 2019
98.67%
Maximum
Oct 2023
75.56%
Average
78.52%
Median
Max Drawdown (5Y) Benchmarks
| Merck & Co Inc | 27.26% |
| Axonics Inc | 61.24% |
| Johnson & Johnson | 27.36% |
| Boston Scientific Corp | 43.49% |
| Ambrx Biopharma Inc (DELISTED) | -- |